Early neurobehavioral outcome after stroke is related to release of neurobiochemical markers of brain damage.
about
S100B in brain damage and neurodegenerationEvidence for a wide extra-astrocytic distribution of S100B in human brainTD-11 workshop report: characterization of monoclonal antibodies to S100 proteins.A panel of neuron-enriched proteins as markers for traumatic brain injury in humans.Serum S100B levels in patients with lupus erythematosus: preliminary observation.Molecular and cellular immune responses to ischemic brain injuryHigh-sensitivity C-reactive protein, lipoprotein-related phospholipase A2, and acute ischemic stroke.Correlation of levels of neuronal and glial markers with radiological measures of infarct volume in ischaemic stroke: a systematic review.Serum S100B protein levels are correlated with subclinical neurocognitive declines after carotid endarterectomyCorrelative study between neuron-specific enolase and blood sugar level in ischemic stroke patientsDifferential temporal expression of S100β in developing rat brain.Serial measurement of neuron specific enolase improves prognostication in cardiac arrest patients treated with hypothermia: a prospective study.Comparative evaluation of risk factors, outcome and biomarker levels in young and old acute ischemic stroke patients.Circulating damage marker profiles support a neuroprotective effect of erythropoietin in ischemic stroke patientsCorrelation of Brain Biomarker Neuron Specific Enolase (NSE) with Degree of Disability and Neurological Worsening in Cerebrovascular StrokeNeuron-specific enolase as a marker for acute ischemic stroke: a systematic review.Brain metastases at the time of presentation of non-small cell lung cancer: a multi-centric AERIO analysis of prognostic factorsBiomarker evidence for mild central nervous system injury after surgically-induced circulation arrest.Predictive value of circulating interleukin-6 and heart-type fatty acid binding protein for three months clinical outcome in acute cerebral infarction: multiple blood markers profiling study.Failure of intraoperative jugular bulb S-100B and neuron-specific enolase sampling to predict cognitive injury after carotid endarterectomy.Induction of immunologic tolerance to myelin basic protein prevents central nervous system autoimmunity and improves outcome after stroke.Immune and inflammatory responses to stroke: good or bad?NSE, a potential biomarker, is closely connected to diabetic peripheral neuropathy.The Relationship of Serum S100B Levels with Infarction Size and Clinical Outcome in Acute Ischemic Stroke Patients.Circulating microRNAs as potential non-invasive biomarkers for the early detection of hypertension-related stroke.8-hydroxy-2'-deoxyguanosine and cardiovascular disease: a systematic review.Point-of-Care-Testing in Acute Stroke Management: An Unmet Need Ripe for Technological Harvest.Induction of Neurorestoration From Endogenous Stem Cells.Serum neuron-specific enolase is elevated as a novel indicator of diabetic retinopathy including macular oedema.Acute sleep deprivation increases serum levels of neuron-specific enolase (NSE) and S100 calcium binding protein B (S-100B) in healthy young men.Glial S100B is elevated in serum across the spectrum of West Nile virus infection.Sensitization to brain antigens after stroke is augmented by lipopolysaccharide.The impact of intrauterine infection on fetal brain damage assessed by S100B protein concentrations in umbilical cord arteries.Protein expression profiling in the hippocampus after focal cerebral ischemia injury in rats.The association between FABP7 serum levels with survival and neurological complications in acetaminophen-induced acute liver failure: a nested case-control study.Modern stroke unit.Effect of stress doses of hydrocortisone on S-100B vs. interleukin-8 and polymorphonuclear elastase levels in human septic shock.Serum S-100beta protein and postoperative neurological dysfunction--ready for prime time?Tryptophan metabolism and oxidative stress in patients with Huntington's disease.Novel surrogate markers for acute brain damage: cerebrospinal fluid levels corrrelate with severity of ischemic neurodegeneration in the rat.
P2860
Q28593720-715704ED-8985-41D0-A91D-A26988D54544Q30828914-FC85C99A-53C4-4FFC-9B7B-5A155BDF5475Q33638693-F43A5284-58F7-47DE-825A-137B2DE9EAA1Q33657708-DEC5383D-38C0-4A81-93A8-ABB363E157BBQ33941483-681B7BE7-94BA-4F7B-8B5A-506B41A66A32Q34016804-44D6AB58-5C6F-4082-A281-DD9E6FAB8E0EQ34036010-25F0345E-15CA-4A6B-9199-20071F6CE571Q34088810-955AB980-5DFE-4508-9D4B-0E65653A16E1Q34561898-E407033A-281D-4422-B3B3-BC7A91A5B63FQ35067529-54D52E2B-43C1-4FFA-A194-F5F4DF67920BQ35190059-79C2556E-7D34-4C3A-8EFD-7850FF34D3D7Q35744872-3D3C955C-B284-4E2D-BFE8-F5067BECEACDQ35779799-DE25D72E-F293-43E0-90E2-6D38AFF1E2B8Q35876807-52872724-D921-49EE-9586-B68F59C07F5DQ35980578-407A19E6-8455-4DC8-904D-F3CEDEFC5B33Q36241156-E565D13F-2F51-4FA8-B467-CCFE266BA0E0Q36622856-402CBDAF-C18B-48A1-93B7-34DFCDA7E53EQ36807376-E9E20773-5000-4DB7-AE3D-79888BF3832DQ36902376-E8C6A6FC-26EE-4D02-8414-CB2BFB411C92Q37145526-3BACAB4A-114B-4695-A713-8A8F9A1DF7CAQ37158146-EF42BDAA-0735-49E6-A124-4B333CB31872Q37277232-D009E207-408D-4C20-A0FF-A80A8797B556Q37277998-83168C7A-4684-4121-B6CA-5288FE1E63F5Q37704016-B8FBD5D7-FF29-4DA7-9598-0E9EFEB1B364Q38153192-5BCCDD00-1469-4986-AFC2-188BC397CE98Q38254020-43CC3657-9C4D-4F88-8114-3639E6DE871AQ38644674-13571848-AB30-4B98-BAD3-D326304438A5Q38703435-8569E769-818A-493E-A6C0-E55633D75412Q39123923-5D36E77B-F986-46B6-B044-A8AEBE0EEFDEQ39262156-5C878CFD-5B1C-4415-B61F-D6E301B58417Q40287128-A3D55E14-08F6-4D5A-8756-FBC2EF847DAAQ40384276-57DAA5C6-91A5-4A79-81DF-0203E957672DQ40974053-683F862B-DF29-4FB7-900C-2C672256F598Q41930615-E2DA68A1-1C10-48F0-86AF-52F5FAD795D7Q42370987-1962FDCC-56A2-481C-9C84-7E39ABEC1833Q43633518-A94CCC39-8607-4826-83CC-EB4DD5468C66Q44613105-6FB96ED3-016E-4412-9A13-60A16E0EFA92Q45017979-F24457E6-5EA0-49E8-ABC7-16DDECB670D4Q45296591-828BEF48-2247-4DDC-8DA6-907D570764BFQ46497516-D3130442-A72E-42E7-AA42-3B1D82EAEF9E
P2860
Early neurobehavioral outcome after stroke is related to release of neurobiochemical markers of brain damage.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Early neurobehavioral outcome ...... mical markers of brain damage.
@en
Early neurobehavioral outcome ...... mical markers of brain damage.
@nl
type
label
Early neurobehavioral outcome ...... mical markers of brain damage.
@en
Early neurobehavioral outcome ...... mical markers of brain damage.
@nl
prefLabel
Early neurobehavioral outcome ...... mical markers of brain damage.
@en
Early neurobehavioral outcome ...... mical markers of brain damage.
@nl
P2093
P356
P1433
P1476
Early neurobehavioral outcome ...... mical markers of brain damage.
@en
P2093
P304
P356
10.1161/01.STR.30.6.1190
P407
P577
1999-06-01T00:00:00Z